Semaglutide with B12 for Weight Loss — What Do the Reviews Actually Say?

Where does the semaglutide-plus-B12 idea come from, and is it used in the UK?

The practice of mixing semaglutide with vitamin B12 developed in compounding pharmacies in the United States, where individual pharmacies can prepare non-standard drug formulations for specific patients. The rationale offered is twofold: B12 is sometimes added to try to offset potential energy-dip side effects, and it makes injections feel more familiar to people used to vitamin infusion clinics. Neither the MHRA nor any UK regulatory authority has approved a combined semaglutide-B12 product. No such formulation holds a UK marketing authorisation.

In the UK, semaglutide for weight management is licensed as Wegovy, a precisely manufactured, quality-controlled pen produced by Novo Nordisk. The formulation has been reviewed by the MHRA, studied across large phase-3 clinical trials, and appraised by NICE. Adding B12 to the mix is not part of any of that evidence base. When UK-based reviewers describe using a semaglutide-and-B12 product, they are almost certainly describing something sourced outside the licensed UK supply chain, which carries real risks of variable potency, contamination, or outright counterfeiting. The MHRA has seized large quantities of fake and illegally traded weight-loss pens in recent enforcement operations and continues to warn the public about products sold through social media and unverified online sellers.

If you have come across reviews of this combination and wondered whether there is something the licensed version is missing, the short answer is no. The B12 component adds nothing to semaglutide's mechanism of action.

Does vitamin B12 actually support weight loss alongside semaglutide?

Vitamin B12 is an essential nutrient involved in neurological function, DNA synthesis and the formation of red blood cells. A deficiency can cause fatigue, which is why some proponents suggest pairing it with semaglutide treatment, where nausea in the early weeks can reduce appetite and food intake. However, B12 deficiency as a consequence of semaglutide use has not been established in the published trial data. STEP 1, the pivotal phase-3 trial published in the New England Journal of Medicine, enrolled 1,961 adults and ran for 68 weeks, B12 supplementation was not part of the protocol, and average weight reduction of around 15% was achieved without it.

There is a separate, well-established clinical context in which B12 monitoring matters: long-term metformin use in type 2 diabetes is associated with reduced B12 absorption. Some people using semaglutide also take metformin for diabetes management, so their prescriber may monitor B12 for that reason. That is a different situation from the idea that B12 enhances semaglutide's weight-loss effect, it does not. You can read more about how semaglutide works for weight management on our semaglutide overview page.

If you are concerned about your B12 levels for any reason, that is worth raising with your GP or prescriber as a separate conversation, not something to address by sourcing an unlicensed combined product.

What do reviews of licensed Wegovy actually show?

Reviews of licensed Wegovy (the product with the actual evidence base) tell a more nuanced story than the headline trial figures suggest. Real-world accounts consistently echo three themes: side effects are front-loaded in the early weeks and become manageable for most people; the appetite reduction feels qualitatively different from simply eating less; and results vary considerably depending on dose reached, lifestyle changes alongside treatment, and individual physiology.

The weight-loss reviews for Wegovy that our clinical team considers most useful are those that describe the whole journey (the dose-escalation period, the adjustment to GI symptoms, and the changes in how hunger feels over time) rather than a single number at a single point. You can also find a broader set of experiences documented in semaglutide user reviews covering the treatment as a whole.

One practical detail that comes up regularly in reviews: people find it easier to build the weekly injection into a fixed routine. Keeping the pen in the fridge door and pairing the injection with the same evening each week removes the mental load of remembering. Small habits, but they matter for adherence, and adherence matters for results.

For context on what the real-world cost of licensed treatment looks like in the UK, our Wegovy cost page sets out the landscape honestly, including what a legitimate private prescription includes beyond the medicine itself.

Should you be concerned about reviews promoting unlicensed semaglutide-B12 products?

Yes, and not just on principle. The MHRA's Yellow Card reporting system exists partly because patient safety signals from unlicensed products can emerge only when people report them. Fake pens have previously been found to contain insulin rather than semaglutide, with potentially life-threatening consequences for people who are not diabetic. Products sold without a prescription from an unverified source, often promoted through social-media reviews, carry risks that no B12 addition can offset.

Reviews of unlicensed combinations are also inherently unreliable as evidence. The reviewer often does not know the actual semaglutide content of what they injected. They cannot know whether any result came from the semaglutide, a placebo effect, the dietary changes they made alongside it, or a product that contained something else entirely. That is not scepticism about the reviewer's honesty, it is simply what unverified formulations mean in practice.

Our Wegovy treatment page covers the licensed product in full, including guidance on whether you can take Wegovy with prednisone and other common medication queries. If you have questions about an interaction or an unusual product you have seen advertised, our support team is available seven days a week. For anything affecting your health urgently, contact your GP or 111.